1. Home
  2. NVCR vs RNST Comparison

NVCR vs RNST Comparison

Compare NVCR & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • RNST
  • Stock Information
  • Founded
  • NVCR 2000
  • RNST 1904
  • Country
  • NVCR Jersey
  • RNST United States
  • Employees
  • NVCR N/A
  • RNST N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • RNST Major Banks
  • Sector
  • NVCR Health Care
  • RNST Finance
  • Exchange
  • NVCR Nasdaq
  • RNST Nasdaq
  • Market Cap
  • NVCR 1.8B
  • RNST 1.8B
  • IPO Year
  • NVCR 2015
  • RNST N/A
  • Fundamental
  • Price
  • NVCR $17.49
  • RNST $34.78
  • Analyst Decision
  • NVCR Buy
  • RNST Buy
  • Analyst Count
  • NVCR 5
  • RNST 5
  • Target Price
  • NVCR $26.60
  • RNST $39.50
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • RNST 408.3K
  • Earning Date
  • NVCR 10-30-2024
  • RNST 10-22-2024
  • Dividend Yield
  • NVCR N/A
  • RNST 2.55%
  • EPS Growth
  • NVCR N/A
  • RNST 6.88
  • EPS
  • NVCR N/A
  • RNST 3.09
  • Revenue
  • NVCR $549,964,000.00
  • RNST $685,818,000.00
  • Revenue This Year
  • NVCR $16.23
  • RNST N/A
  • Revenue Next Year
  • NVCR $6.09
  • RNST $35.64
  • P/E Ratio
  • NVCR N/A
  • RNST $11.16
  • Revenue Growth
  • NVCR 8.33
  • RNST 8.35
  • 52 Week Low
  • NVCR $10.87
  • RNST $24.02
  • 52 Week High
  • NVCR $24.74
  • RNST $37.40
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • RNST 62.45
  • Support Level
  • NVCR $15.61
  • RNST $31.08
  • Resistance Level
  • NVCR $17.31
  • RNST $34.89
  • Average True Range (ATR)
  • NVCR 1.29
  • RNST 0.90
  • MACD
  • NVCR 0.05
  • RNST 0.23
  • Stochastic Oscillator
  • NVCR 11.59
  • RNST 99.23

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: